Core 2: Structural Cell Biology (SCB) Core

核心 2:结构细胞生物学 (SCB) 核心

基本信息

项目摘要

SUMMARY - CORE 2: STRUCTURAL CELL BIOLOGY (SCB) A major challenge for cancer structural biology in SBDR4 is to structurally define the DNA repair (DR) proteins and assemblies that maintain genomic integrity. However. DR proteins and complexes have encoded flexibility and function in spatially and temporally coordinated complexes that make their structural characterizations so challenging. With SBDR investigators, Core 2, the Structural Cell Biology (SCB) Core overcomes these extreme challenges by providing access to and expertise on cutting-edge structural biology technologies needed to probe DR proteins and complexes and not available in individual research institutions. Aim 1. Determine structures, conformations and assembly states. The SCB Core, centered at a national synchrotron facility, will provide macromolecular crystallography (MX) and small angle X-ray scattering (SAXS) data collection and beamline scientist-level expertise for SBDR members. MX provides high resolution atomic structures, while SAXS can rapidly assess flexibility, solution conformation(s), and assemblies. SCB SAXS includes ligand or buffer screening and assessing DNA bending, via GOLD-SAXS. Aim 2. Detect folds and conformations for integrative structural biology. Analysis of large complexes in the Projects, by megadalton structural mass spectrometry (MS) and with SAXS-validated structure predictions, will provide testable hypotheses on their own, or will accelerate CryoEM studies at individual institutes. Aim 3. Define molecular architectures in reconstituted systems and in the cell through synchrotron soft X-ray tomography (SXT) of reconstituted phase transitions and cells and super-resolution fluorescence measurements for quantitative measurements of DR assemblies, that would otherwise be problematic for traditional structural methods. The SCB Core is centered at the Advanced Light Source (ALS) synchrotron, where three beamlines (12.3.1, 8.3.1, and National Center for X-ray Tomography/NCXT) will provide SAXS, MX, and SXT data collection to SBDR members. For enabling access to additional structural technologies and capabilities, SCB has branches at Calgary (MS), New York (super-resolution microscopy), Oxford (MX), and Scripps (MX). All four Projects will use the SCB Core, regardless of structural expertise in member laboratories, to optimally and efficiently address Project structural and mechanistic Aims in ways that typical laboratories and beamline visits cannot or do not do. Together, these SCB modalities allow SBDR-5 interrogation of dynamic DR machines from atomic to cellular scales. The broad, long range objective of the SCB Core is to support SBDR Projects to determine the impact of sequence variations, the means to dissect multiple functions, and the mechanisms whereby flexible and dynamic DR machinery functions.
摘要 - 核心 2:结构细胞生物学 (SCB) SBDR4 中癌症结构生物学的一个主要挑战是从结构上定义 DNA 修复 (DR) 蛋白 和保持基因组完整性的组件。然而。 DR 蛋白和复合物具有编码灵活性 并在空间和时间协调的复合体中发挥作用,这使得它们的结构特征如此 具有挑战性的。与 SBDR 研究人员合作,结构细胞生物学 (SCB) 核心 Core 2 克服了这些问题 通过提供尖端结构生物学技术的机会和专业知识来应对极端挑战 需要探测 DR 蛋白和复合物,但个别研究机构不具备。 目标 1. 确定结构、构象和组装状态。 SCB 核心,以国家为中心 同步加速器设施,将提供大分子晶体学 (MX) 和小角度 X 射线散射 (SAXS) 为 SBDR 成员提供数据收集和光束线科学家级专业知识。 MX 提供高分辨率原子 结构,而 SAXS 可以快速评估灵活性、解决方案构象和组件。 SCB萨克斯 包括通过 GOLD-SAXS 筛选配体或缓冲液以及评估 DNA 弯曲。 目标 2. 检测综合结构生物学的折叠和构象。大型复合物的分析 通过兆道尔顿结构质谱 (MS) 和经过 SAXS 验证的结构预测的项目将 自己提供可检验的假设,或者将加速各个研究所的 CryoEM 研究。 目标 3. 通过同步加速器软 X 射线定义重构系统和细胞中的分子结构 重建相变和细胞的断层扫描 (SXT) 以及超分辨率荧光 DR 组件的定量测量,否则会出现问题 传统的结构方法。 SCB 核心以先进光源 (ALS) 同步加速器为中心,其中三个光束线(12.3.1、 8.3.1 和国家 X 射线断层扫描中心/NCXT)将提供 SAXS、MX 和 SXT 数据收集 SBDR 成员。为了获得额外的结构技术和能力,SCB 设有分支机构 卡尔加里(MS)、纽约(超分辨率显微镜)、牛津(MX)和斯克里普斯(MX)。 所有四个项目都将使用 SCB 核心,无论成员实验室的结构专业知识如何,以最佳方式 并以典型实验室和光束线的方式有效地解决项目结构和机械目标 访问不能或不做。这些 SCB 模式共同允许 SBDR-5 询问动态 DR 从原子到细胞尺度的机器。 SCB 核心的广泛、长期目标是支持 SBDR 确定序列变异影响的项目、剖析多个功能的方法以及 灵活、动态的灾难恢复机制发挥作用的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gregory L Hura其他文献

Gregory L Hura的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gregory L Hura', 18)}}的其他基金

High quality and high throughput Small‐Angle X‐ray Scattering
高质量和高通量小角 X 射线散射
  • 批准号:
    10201649
  • 财政年份:
    2017
  • 资助金额:
    $ 74.51万
  • 项目类别:
High quality and high throughput Small‐Angle X‐ray Scattering
高质量和高通量小角 X 射线散射
  • 批准号:
    10506286
  • 财政年份:
    2017
  • 资助金额:
    $ 74.51万
  • 项目类别:
High quality and high throughput Small‐Angle X‐ray Scattering
高质量和高通量小角 X 射线散射
  • 批准号:
    10708028
  • 财政年份:
    2017
  • 资助金额:
    $ 74.51万
  • 项目类别:
Core 2: Structural Cell Biology (SCB) Core
核心 2:结构细胞生物学 (SCB) 核心
  • 批准号:
    10492052
  • 财政年份:
    2001
  • 资助金额:
    $ 74.51万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 74.51万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 74.51万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.51万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.51万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 74.51万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.51万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 74.51万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 74.51万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 74.51万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.51万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了